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Abstract
introduction: the deadly threat of systemic infections
with coagulase negative Staphylococcus lugdunensis de-
spite an appropriate antibiotic therapy has only recent-
ly been recognized. the predominant infectious focus
observed so far is left-sided native heart valve endo-
carditis,  but  bone  and  soft  tissue  infections,  septi-
caemia and vascular catheter-related bloodstream in-
fections have also been reported. we present a patient
with a fatal Staphylococcus lugdunensis septicaemia fol-
lowing zoster bacterial superinfection of the pelvic re-
gion.  
case presentation: a 71-year old male diagnosed with
Igg kappa plasmocytoma presented with a conspicu-
ous weight loss, a hypercalcaemic crisis and acute renal
failure. after initiation of haemodialysis treatment his
condition improved rapidly. However, he developed a
varicella-zoster virus infection of the twelfth thoracic
dermatome requiring intravenous acyclovir treatment.
Four days later the patient presented with a fulminant
septicaemia.  despite  an  early  intravenous  antibiotic
therapy  with  ciprofloxacin,  piperacillin/combactam
and  vancomycin  the  patient  died  within  48  hours,
shortly  before  the  infective  isolate  was  identified  as
Staphylococcus  lugdunensis by  polymerase  chain  reac-
tion.
conclusion: despite  S.  lugdunensis belonging  to  the
family  of  coagulase-negative  staphylococci  with  an
usually  low  virulence,  infections  with  S.  lugdunensis
may be associated with an aggressive course and high
mortality. this is the first report on a Staphylococcus
lugdunensis septicaemia following a zoster bacterial su-
perinfection of the pelvic region.
IntRoductIon
Staphylococcus lugdunensis was first described in 1988
[1].  It  belongs  to  the  family  of  coagulase-negative
staphylococci (conS), which are skin commensals and
historically  regarded  as  pathogens  of  low  virulence.
despite their resistance to a large number of antibi-
otics, infections with conS clinically manifest as less
severe, subacute diseases with a low mortality rate [2].
In contrast to other conS, S.  lugdunensis infections
exhibit a particular aggressive course associated with a
high mortality. thus S. lugdunensis, although a conS,
should be regarded as equivalent to S.  aureus when
considering the pathogenic potential. [3]. S. lugdunen-
sis is a member of the normal skin flora and colonizes
predominantly  the  perineal  region,  especially  the  in-
guinal  folds  [4-6].  Infectious  isolates  are  mostly  de-
rived from skin- and less frequently from vascular-re-
lated infections. this pathogen occurs in patients with
underlying diseases, especially immunosuppressed pa-
tients [7-11], but has also been described in otherwise
healthy people [5, 12, 13]. due to the susceptibility of
S.  lugdunensis to  a  large  number  of  antimicrobial
agents,  these  infections  are  often  underestimated  in
their severity by physicans  –  explaining why S. lug-
dunensis is also called ‘a wolf in sheep’s clothing’ [13]. 
Here, we report a case of fulminant and fatal septi-
caemia with S. lugdunensis following a pelvic varicella-
zoster virus infection in an immunodeficient patient.
despite early and appropriate antibiotic treatment, the
patient died within 48 hours.
caSE PRESEntatIon
a  71  year-old  male  was  diagnosed  with  Igg  kappa
plasmocytoma 15 months earlier, exhibiting an exten-
sive bone marrow infiltration of more than 60%. a re-
nal involvement was suspected by a proteinuria of 1.8
g/die,  including  a  Bence-Jones  proteinuria,  and  a
chronic  renal  insufficiency  stage  3  without  further
evaluation of the underlying renal disease. after im-
plantation  of  a  central  port-catheter  system  he  re-
ceived a chemotherapeutic regime consisting of vin-
cristine, doxorubicin and dexamethasone for the next
four  months.  His  excellent  physical  constitution  al-
lowed the subsequent autologous bone marrow trans-
plantation  eight  months  later.  as  renal  insufficiency
progressed,  an  autologous  arteriovenous  fistula  was
created pre-emptively. Six months later he presented
with a conspicuous weight loss, a hypercalcaemic crisis
and acute renal failure. on clinical examination the pa-
tient was afebrile. the cardiac auscultation revealed a
pansystolic murmur, first described three years before,
suggesting a mitral valve insufficiency. His initial labo-
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3.8  mmol/l  (reference  range:  2.0  -  2.6  mmol/l),  a
serum phosphate level of 16 mg/dl (reference range:
2.6 - 4.5 mg/dl), a serum creatinine of 7.9 mg/dl (ref-
erence range: 0.5 - 1.1 mg/dl) and a c-reactive protein
(cRP)  of  6.1  mg/dl  (reference  range:  <0.5  mg/dl).
Haemodialysis  treatment  was  initiated,  followed  by
ibandronate  administration.  Serum  calcium  levels
rapidly decreased and the overall condition of the pa-
tient  improved.  However,  he  developed  a  varicella-
zoster virus infection of the left twelfth thoracic der-
matome (th12) requiring intravenous treatment with
acyclovir. the diagnosis was based on the typical clini-
cal findings, including limitation of the skin lesions to
the left dermatome th12, and was confirmed by the
dermatology department. the zoster lesions were su-
perficial  with  small  vesicles  and  bullae,  but  without
haemorrhagic lesions, crusts or any signs of bacterial
superinfection. Four days later the patient developed a
temperature of 39.5ﾰc and chills. the laboratory find-
ings at this time included a normal leukocyte count, a
cRP level of 13.2 mg/dl, which further increased on
the following day and persisted over 20 mg/dl. urine
examination, an abdominal ultrasound examination, a
computed tomography of chest and cranium as well as
a three phase bone scan could not reveal the infectious
focus. on clinical examination there was no change of
the known cardiac murmur and no signs of septic em-
bolization or skin lesions other than his zoster lesions.
the latter by now included haemorrhagic vesicle ex-
tending to the dermis, disseminated pustules as well as
lesions covered by crusts, but no signs of an erysipel
or abscess. the central port and the haemodialysis fis-
tula showed no clinical signs of infection. Four sets of
aerobic and anaerobic blood cultures were taken from
each the peripheral veins as well as from the central
port, which was used for the first time since approxi-
mately 6 months to draw the blood cultures. an intra-
venous  antibiotic  therapy  was  started  with
piperacillin/combactam (3 x 2.5 g/day), ciprofloxacin
(2 x 250 mg/day) and vancomycin (initial dose 1 g).
all blood cultures showed rapid bacterial growth with-
in  few  hours.  there  was  no  apparent  difference  in
time to positivity between peripheral vein and central
port  drawn  blood  cultures.  Microscopy  revealed  a
gram-positive, but coagulase-negative staphylococcus.
despite early antibiotic treatment, the patient’s condi-
tion rapidly deteriorated, impeding the realisation of a
transoesophageal  echocardiogram  to  exclude  endo-
carditis. the patient died 48 hours after onset of clini-
cal symptoms. unfortunately, an autopsy was strictly
refused by the patient’s relatives. the antibiotic sus-
ceptibility  pattern  arrived  on  the  day  of  death,  48
hours  after  the  beginning  of  antibiotic  treatment. 
Except for a resistance towards penicillin, the isolated
microorganism  was  sensitive  to  all  antimicrobial
agents  tested  (isoxazolyl  penicillin,  piperacillin/
tacobactam,  cefazolin,  cefuroxim,  imipenem,  ery-
thromycin,  clindamycin,  gentamycin,  cotrimoxazol,
doxycyclin,  ciprofloxacin,  levofloxacin,  fosfomycin,
fusidic acid, linezolid, vancomycin, rifampicin) includ-
ing all three antibiotics primarily administered. at the
same time, the isolated conS was identified as S. lug-
dunensis by polymerase chain reaction.
dIScuSSIon and REvIEw oF tHE lItERatuRE
Staphylococcus  lugdunensis belongs  to  the  family  of
conS and is frequently found as skin commensal of
the perineal region and inguinal folds [4-6]. Yet it can-
not be considered a typical member of the conS fam-
ily as it increasingly has become known for nosocomi-
al and community-acquired infections with a rather ag-
gressive course and a high mortality rate, mirroring the
virulent coagulase-positive Staphylococcus aureus. Most
frequently, S. lugdunensis isolates were detected with
left-sided native valve endocarditis, less frequent pros-
thetic valve endocarditis, pacemaker-related endocardi-
tis  or  myocarditis  [10,  14-19].  In  addition,  skin  and
soft tissue infections have been described [5], rarely
blood  stream  infections  including  sepsis  or  septic
shock [20], bone and joint infections [8, 21, 22], cen-
tral nervous system infections [23], peritonitis [24, 25],
urinary tract [26] or ocular infections [27]. despite its
apparent virulence, only case reports or small patient
studies have been published since 1989. only recently
publications on fatal infections emerge and highlight
the pathological potential of this atypical conS [3].
the low incidence in the past might be explained by
the  fact  that  most  microbiology  laboratories  do  not
routinely identify conS isolates to the species level.
Yet case of severe sepsis caused by an conS with an
unusually sensitive antibiotic susceptibility pattern the
suspicion for S. lugdunensis should be raised. 
S.  lugdunensis is  a  gram-positive,  catalase-positive
coccus, occurring singly, in pairs or short chains with
varying colony morphology and pigmentation [1]. de-
spite the lack of secreted coagulase, some S. lugdunen-
sis strains express a membrane-bound coagulase, lead-
ing to a positive clumping test, which usually indicates
S. aureus [28]. In addition, a fibrinogen binding sur-
face  protein  (Fbl)  with  considerable  similarity  to
clumping factor a (clfa) of S.  aureus is expressed,
which promotes bacterial adhesion to immobilized fib-
rinogen in animal models of endocarditis [29]. Some
isolates  demonstrate  hemolysis  on  blood  agar  when
streaked in proximity with beta-hemolytic staphylococ-
cal strains [30, 31]. other identified virulence factors
of  S.  lugdunensis include  the  production  of  an  es-
terase and a lipase as well as the ability to bind extra-
cellular matrix proteins, such as collagen type I and Iv,
thrombospondin,  plasminogen,  fibronectin,  vit-
ronectin,  laminin  and  human  Igg  [32,  33].  S.  lug-
dunensis produces  tannase,  which  degrades  bacterio-
static and toxic tannins secreted by many microorgan-
isms of the gastrointestinal tract [34]. the accessory
gene regulator (agr) system, which has been identified
in different staphylococcus strains as regulators of vir-
ulence factors, is also detectable in S. lugdunensis, but
its impact on the reported virulence still needs to be
elucidated [35]. thus, the conS-associated ability of
S.  lugdunensis to colonize and form biofilms on the
surfaces of medical devices combined with virulence
factors,  which  are  more  reminiscent  of  S.  aureus,
highlight the pathogenic potential of this organism.
S. ludgunensis can be identified by conventional bi-
ological  methods  such  as  pyrrolidonyl  arylamidase
(PYR) activity, the presence of ornithine decarboxy-
lase and a correct interpretation of the oxcillin mini-
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troduction of a characteristic eikenella corrodens-like
odor on colombia sheep blood agar combined with
colony pleomorphism and prominent ￟-hemolysis af-
ter  2  days  of  incubation,  confirmed  by  aPI-Id-32
Staph to further analyze conS, led to an 11-fold in-
crease in detection of S.  lugdunensis isolates in skin
and soft tissue infections in a danish community [36].
these traditional microbiologic tests are effective, but
timely for an accurate identification of this aggressive
conS. In case of a fulminant septic course the diag-
nosis comes too late to influence outcome. alterna-
tively  S.  lugdunensis can  be  identified  by  molecular
methods such as an analysis of ribosomal ribonucleic
acid  (rRna)  restriction  fragment  length  polymor-
phism [28], real-time polymerase chain reaction (PcR)
assays which amplify the 16S rRna sequence [37] or
blot hybridization of a 600-base-pair sequence of the
heat shock protein gene (hsp60) [38].  In recent publi-
cations conventional [39] as well as quantitative multi-
plex real-time PcR assays [40] identify S. lugdunensis
by amplification of the fbl gene, which encodes a fib-
rinogen-binding  protein,  or  the  tana gene  [41]  for
tannase.
S. lugdunensis isolates exhibit susceptibility towards
a large number of antibiotics in MIc tests, often in-
cluding  penicillin,  macrolides,  cephalosporins,  b-lac-
tams,  aminoglycosides,  chinolons,  rifampicin,  fos-
fomycin,  glycopeptides,  sulphonamides,  chloram-
phenicol and others [42, 43]. only few isolates with b-
lactamase activity or oxacillin-resistance [3] have been
described.  nevertheless,  our  patient  died  despite  an
early  and  appropriate  antibiotic  treatment  with  van-
comycin,  piperacillin/combactam  and  ciprofloxacin.
How can such a virulence be explained despite a high
susceptibility to most antibiotics? with regard to van-
comycin, Frank et al. described a vancomycin toler-
ance of 93 % of clinical S. lugdunensis isolates despite
susceptibility in the in vitro testing, as defined by a
minimal bactericidal concentration (MBc)/MIc ratio
of  ≥32  [42].  this  tolerance  to  vancomycin  and  te-
icoplanin was verified by time-kill curve methodology
[43]. In contrast to glycopeptides, linezolid was suc-
cessfully employed in the recent past [11, 42]. thus, if
a S. lugdunensis infection is suspected, a combined an-
timicrobial  therapy  should  be  considered  which  in-
cludes linezolid. It is absolutely critical to identify S.
lugdunensis as  fast  as  possible  by  applying  the  new
PcR-based  methods  described  above  in  contrast  to
much more time-requiring microbiological tests.
In our patient the source of the S. lugdunensis in-
fection can only be a matter of speculation, as a post-
mortem autopsy was denied. an endocarditis without
any embolic signs or alteration of the heart murmur
seems unlikely. Furthermore, the rapid course, mirror-
ing a septic shock, argues against an endocarditis. S.
lugdunensis has  been  reported  to  be  responsible  for
vascular catheter-related bloodstream infections (cRB-
SI) [20]. Yet in our patient the central catheter initially
did not raise any suspicion of infection and was used
for the first time in six months to draw the blood cul-
tures. In addition, both diagnostic criteria to confirm a
cRBSI  diagnosis,  as  defined  by  the  Infectious  dis-
eases Society of america [45], are not fulfilled: the ra-
tio of positive blood cultures drawn through the port
and through a peripheral vein was 1:1 and not as sug-
gested for cRBSI 5:1 or above. the second criterion
of differential time to positivity, which means blood
cultures drawn from a central venous catheter to be-
come  positive  two  hours  earlier  than  simultaneously
drawn  blood  cultures  from  a  peripheral  vein,  was
equally not met, arguing against a cRBSI in our case.
there are several factors indicating that the herpetic
lesions  are  the  most  probable  site  of  bacterial  en-
trance. S. lugdunensis is capable and known to cause
soft tissue infections and abscesses [5]. the zoster in-
fection preceded the fatal septicaemia by 4-6 days. the
herpetic lesions localized at the pelvic girdle region,
known to host S. lugdunensis as skin commensal. they
showed multiple breaks in the skin surface, allowing
the entrance of bacteria. Most importantly, the herpet-
ic lesions included disseminated pustules as sign for a
bacterial superinfection.
there are striking clinical similarities to a recently
reported  concomitant  S.  lugdunensis and  cy-
tomegalovirus  infection  in  an  immune  deficient  pa-
tient with scleroderma [10], which is suggestive for a
common infectious pathway. Both patients were im-
munosuppressed, featured a co-infection with S. lug-
dunensis and a herpes virus, showed a systemic inflam-
matory response syndrome (SIRS) and rapidly died de-
spite an appropriate antibiotic therapy. Bacterial super-
infections of zoster lesions and secondary bacterial in-
fections following respiratory viral infection are com-
mon, but the phenomenon of “lethal synergism” is an
intriguing  new  pathogenic  mechanism  and  was  first
proposed by Beadling and Slifka in 2004 [46]. differ-
ent murine models were established to further analyze
this mechanism and suggest several factors to cause
the high and rapid lethality: a thousandfold increased
bacterial titer in solid organs during an acute viral chal-
lenge, an increased inflammatory cytokine production
or  a  reduced  antibacterial  granulocyte  defence  as  a
consequence of the innate antiviral immune response
[46-48]. given the aggravating value of coinfections
between influenza virus and S. aureus, it is tempting
to speculate that a similar situation exists in coinfec-
tions with S. lugdunensis and herpes viruses.
concluSIon
Here we report a case of fulminant and fatal septi-
caemia with S. lugdunensis, following a pelvic varicel-
la-zoster  virus  infection  in  an  immune-deficient  pa-
tient. the most likely bacterial entry site was a bacteri-
al  superinfection  of  herpes  zoster  lesions  of  der-
matome th12. despite S. lugdunensis belonging to the
group of conS with a usually low virulence, infec-
tions with S. lugdunensis have recently been associated
with an aggressive course and high mortality. there-
fore early identification and begin of an appropriate
antibiotic therapy which includes linezolid seem cru-
cial for the patient’s survival. to allow a true judge-
ment on incidence estimation of S. lugdunensis infec-
tions as well as their clinical course, conS in infective
isolates should always be characterized to the underly-
ing species, especially when the antibiotic susceptibility
pattern reveals a rather unusual susceptibility to most
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pected  S.  lugdunensis infection,  vancomycin  should
not be considered as the antimicrobial agent of choice
with regard to the reported in vivo tolerance of S. lug-
dunensis to glycopeptides.
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